OpCT-001

N/A

Report date: 2025/03/28 10:21:13

Base Information

Drug NameOpCT-001
Drug Alias NamePhotoreceptor cell therapyOpCT-001
ClassificationCell and gene therapy > Cell therapy > Somatic cell > Photoreceptor precursor cell therapyCell and gene therapy > Cell therapy > Source of cells > iPSC-derived
Mechanisms of ActionStem cell replacements
TargetsUpdating
Therapy Area/IndicationsPrimary Photoreceptor DiseaseRod-Cone InteractionRetinal Diseases +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOpsis Therapeutics LLCBluerock Therapeutics LpFUJIFILM Cellular Dynamics Inc
China Registration ClassN/A

Develop Information

Active CompaniesBluerock Therapeutics Gp LlcBluerock Therapeutics Lp
Inactive CompaniesN/A
Active IndicationsPrimary Photoreceptor DiseaseRod-Cone InteractionRetinal Diseases +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A